INVESTIGATING THE POTENTIAL OF SINGLE-SHOT CO-AMOXICLAV PROPHYLAXIS FOR PREVENTING SURGICAL SITE INFECTIONS IN A TERTIARY CARE HOSPITAL IN PESHAWAR, PAKISTAN
DOI:
https://doi.org/10.69723/njms.03.03.0404Keywords:
Surgical Site Infections, Antibiotic Prophylaxis, Co-Amoxiclav, Surgical Procedures, Patient SafetyAbstract
BACKGROUND: Patients undergoing surgery are at a significant risk of developing surgical site infections (SSIs), which can increase rates of morbidity, mortality, and medical costs. There is a chance that using antibiotics prophylactically for prophylaxis will lower SSIs.
OBJECTIVE: To investigate the potential of a single shot of co-amoxiclav as a preventive measure for preventing surgical site infections.
METHODOLOGY: A retrospective cohort analysis was conducted between 2021 and 2023 at Northwest General Hospital and Research Centre, Peshawar. Examining 1190 patient data, general surgical procedures and single-shot co-amoxiclav prevention were the main topics of interest. Distributions by age, gender, surgical procedure types, and SSIs were all included in the data analysis.
RESULTS: The participants' mean age was 36.22 years, and there were more women (596/1190) than males in every age group. SSIs noted after a single injection were 18/1190 superficial SSIs (1.51%), 7/1190 deep wound infections (0.59%), and 5/1190 deep body cavity infections (0.42%) out of 1190 patients, the overall infection rate was very low, calculated to be 2.52%.
CONCLUSION: The overall infection rate was as low as 2.52% with single-shot co-amoxiclav prophylaxis, highlighting its potential benefit as prevention of SSI.
KEYWORDS: Surgical Site Infections, Antibiotic Prophylaxis, Co-Amoxiclav, Surgical Procedures, Patient Safety.
References
Najjar PA, Smink DS. Prophylactic antibiotics and prevention of surgical site infections. Surg Clin North Am. 2015 Apr;95(2):269-83. https://doi.org/10.1016/j.suc.2014.11.006. Epub 2015 Jan 10.
Bucataru A, Balasoiu M, Ghenea AE, Zlatian OM, Vulcanescu DD, Horhat FG, et al. Factors Contributing to Surgical Site Infections: A Comprehensive Systematic Review of Etiology and Risk Factors. Clinics and Practice. 2024 Feb 1;14(1):52-68. https://doi.org/10.3390/clinpract14010006
Seidelman J, Anderson DJ. Surgical site infections. Infectious Disease Clinics. 2021 Dec 1;35(4):901-29. https://doi.org/10.1016/j.idc.2021.07.006
Cohen NS, Bock JM, May AK. Sepsis and postoperative surgical site infections. J Surg. 2023;174(2):403-5. https://doi.org/10.1016/j.surg.2023.01.006
Amin Yavari S, Castenmiller SM, van Strijp JA, Croes M. Combating implant infections: shifting focus from bacteria to host. Advanced Materials. 2020 Oct;32(43):2002962. https://doi.org/10.1002/adma.202002962
Ullah K, Dogar AW, Jan Z, Bilal H, Tahir MJ, Hamza A, et al. Role of antibiotic prophylaxis on surgical site infection prevention in a low-risk population undergoing laparoscopic cholecystectomy: A randomized controlled study. Ann Med Surg (Lond). 2022 Jun 1;78:103804. https://doi.org/10.1016/j.amsu.2022.103804
Dhole S, Mahakalkar C, Kshirsagar S, Bhargava A. Antibiotic prophylaxis in surgery: current insights and future directions for surgical site infection prevention. Clinics. 2023;15(10). https://doi.org/10.7759/cureus.47858
Evans J, Hannoodee M, Wittler M. Amoxicillin Clavulanate. PubMed. Treasure Island (FL): StatPearls Publishing; 2020. https://doi.org/10.1080/1120009X.2022.2051128
Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Bowler U, et al. Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the Anode RCT. PubMed. NIHR Journals Library; 2019. https://doi.org/10.3310/hta23540
Gazal G, Al-Samadani KH, Alsaidalani HM, Karbouji GA, Alharbi AM. A Comparison of Pre-Emptive Co-Amoxiclav, Postoperative Amoxicillin, and Metronidazole for Prevention of Postoperative Complications in Dentoalveolar Surgery: A Randomized Controlled Trial. Int J Environ Res Public Health. 2022 Mar 31;19(7):4178. https://doi.org/10.3390/ijerph19074178
Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Bowler U, Gray J, et al. Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT. Health Technol Assess. 2019 Oct;23(54):1. https://doi.org/10.3310/hta23540
Baertl S, Walter N, Engelstaedter U, Ehrenschwender M, Hitzenbichler F, Alt V, Rupp M. What is the most effective empirical antibiotic treatment for early, delayed, and late fracture-related infections? Antibiotics (Basel). 2022 Feb 22;11(3):287. https://doi.org/10.3390/antibiotics11030287
Alshoubaki O, Al Darabaa Z, Odat O, Qubbaj A, Alhyari RA, Alshare S, et al. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection. 2021 Feb 1;75(1):56-6. https://doi.org/10.5455/medarh.2021.75.56-60
Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Antibiotic prophylaxis for operative vaginal delivery. Cochrane Database Syst Rev. 2020 Mar 26. https://doi.org/10.1002/14651858.CD004455.pub5
Stallard S, Savioli F, McConnachie A, Norrie J, Dudman K, Morrow ES, et al. Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial. Br J Surg. 2022 Aug 6;109(12):1224-31. https://doi.org/10.1093/bjs/znac280
Ahmed Z, Uwechue R, Chandak P, van Dellen D, Barwell J, Heap S, et al. Prophylaxis of Wound Infections-antibiotics in Renal Donation (POWAR). Ann Surg. 2019 Oct 25;272(1):65-71. https://doi.org/10.1097/SLA.0000000000003666
Menon RK, Gopinath D, Li KY, Leung YY, Botelho MG. Does the use of amoxicillin/amoxicillin–clavulanic acid in third molar surgery reduce the risk of postoperative infection? A systematic review with meta-analysis. Int J Oral Maxillofac Surg. 2019 Feb;48(2):263-73. https://doi.org/10.1016/j.ijom.2018.08.002
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Noor Sardar, Amjad Ali Shah, Muhammad Uzair, Ayesha Ali Khan, Salman Zahir
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
